EUVIMEDDescoperă EUVIMED
EditorialOpen access

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply

Takashi Kumada iD, Masanori Atsukawa iD, Taeang Arai iD, Hidenori Toyoda iD, Junko Tanaka iD

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 406-407

DOI: 10.1111/apt.70754 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-05-22. Written by Takashi Kumada and 4 co-authors. Institution: Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan. 10 references. The full text is freely available in PubMed Central.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Authors and institutions

  • Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.

ORCID profiles: Takashi Kumada, Masanori Atsukawa, Taeang Arai, Hidenori Toyoda, Junko Tanaka

Cite

APA

Kumada, T., Atsukawa, M., Arai, T., Toyoda, H., & Tanaka, J. (2026). Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 406-407. https://doi.org/10.1111/apt.70754

Vancouver

Kumada T, Atsukawa M, Arai T, Toyoda H, Tanaka J. Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):406-407. doi:10.1111/apt.70754

BibTeX
@article{Kumada2026,
  author = {Kumada, Takashi and Atsukawa, Masanori and Arai, Taeang and Toyoda, Hidenori and Tanaka, Junko},
  title = {Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {406--407},
  doi = {10.1111/apt.70754}
}
Start for free →